Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice

Published:2019-04 Issue: Volume:22 Page:49-61
ISSN:2212-8778
Container-title:Molecular Metabolism
language:en
Short-container-title:Molecular Metabolism

Author:

Lindén Daniel^ORCID,Ahnmark Andrea,Pingitore Piero,Ciociola Ester,Ahlstedt Ingela,Andréasson Anne-Christine,Sasidharan Kavitha,Madeyski-Bengtson Katja,Zurek Magdalena,Mancina Rosellina M.^ORCID,Lindblom Anna,Bjursell Mikael,Böttcher Gerhard,Ståhlman Marcus,Bohlooly-Y Mohammad,Haynes William G.^ORCID,Carlsson Björn,Graham Mark,Lee Richard,Murray Sue,Valenti Luca^ORCID,Bhanot Sanjay,Åkerblad Peter,Romeo Stefano

Funder

Swedish Research Council

Swedish Heart-Lung Foundation

Swedish federal government

Novonordisk Foundation Grant

Swedish Diabetes Foundation

AstraZeneca

Knut and Alice Wallenberg Foundation

Wilhelm and Martina Lundgren Science Fund

Italian Ministry of Health

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference49 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis;Serfaty;Diabetes and Metabolism,2008

3. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis;Dulai;Hepatology,2017

4. Current and future therapeutic regimens for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH);Younossi;Hepatology,2018

5. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver;Dongiovanni;Journal of Internal Medicine,2018

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct degradation and stabilization of proteins: New horizons in treatment of nonalcoholic steatohepatitis;Biochemical Pharmacology;2024-02

2. Label‐free Raman spectroscopy for the assessment of liver fibrosis;MedComm – Future Medicine;2023-12

3. Gene expression inhibitors for the treatment of liver fibrosis: drugs under preclinical and early clinical investigation;Expert Opinion on Investigational Drugs;2023-11-28

4. A nutrigenetic precision approach for the management of non-alcoholic fatty liver disease;Clinical Nutrition;2023-11

5. Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium–Glucose Cotransporter 2 Inhibitor Therapy;Journal of Clinical Medicine;2023-10-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3